Related references
Note: Only part of the references are listed.High-Mobility Group Boxes Mediate Cell Proliferation and Radiosensitivity via Retinoblastoma-Interaction-Dependent and -Independent Mechanisms
Li-Li Wang et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2012)
HMGB1 gene knockout in mouse embryonic fibroblasts results in reduced telomerase activity and telomere dysfunction
Eva Polanska et al.
CHROMOSOMA (2012)
Clinical correlation of MGMT protein expression and promoter methylation in Chinese glioblastoma patients
Kai Tang et al.
MEDICAL ONCOLOGY (2012)
p53 and its mutants in tumor cell migration and invasion
Patricia A. J. Muller et al.
JOURNAL OF CELL BIOLOGY (2011)
The CD133+ tumor stem-like cell-associated antigen may elicit highly intense immune responses against human malignant glioma
Wei Hua et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Exciting New Advances in Neuro-Oncology The Avenue to a Cure for Malignant Glioma
Erwin G. Van Meir et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
HMGB2 stabilizes p53 by interfering with E6/E6AP-mediated p53 degradation in human papillomavirus-positive HeLa cells
Daekyun Lee et al.
CANCER LETTERS (2010)
Overexpression of High-Mobility Group Box 2 Is Associated with Tumor Aggressiveness and Prognosis of Hepatocellular Carcinoma
Jung-Hee Kwon et al.
CLINICAL CANCER RESEARCH (2010)
Elevated expression of HMGB1 in squamous-cell carcinoma of the head and neck and its clinical significance
Yong Liu et al.
EUROPEAN JOURNAL OF CANCER (2010)
Theaflavins retard human breast cancer cell migration by inhibiting NF-κB via p53-ROS cross-talk
Arghya Adhikary et al.
FEBS LETTERS (2010)
Overexpression of high-mobility group box 1 correlates with tumor progression and poor prognosis in human colorectal carcinoma
Xingjun Yao et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Prognostic value of O6-methylguanine-DNA methyltransferase status in glioblastoma patients, assessed by five different methods
Lucie Karayan-Tapon et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma
Andreana L. Rivera et al.
NEURO-ONCOLOGY (2010)
Massively Parallel Signature Sequencing and Bioinformatics Analysis Identifies Up-Regulation of TGFBI and SOX4 in Human Glioblastoma
Biaoyang Lin et al.
PLOS ONE (2010)
Release of HMGB1 in Response to Proapoptotic Glioma Killing Strategies: Efficacy and Neurotoxicity
Marianela Candolfi et al.
CLINICAL CANCER RESEARCH (2009)
Involvement of High Mobility Group B Proteins in Cisplatin-Induced Cytotoxicity in Squamous Cell Carcinoma of Skin
Ashok Sharma et al.
DNA AND CELL BIOLOGY (2009)
Chromatin-associated proteins HMGB1/2 and PDIA3 trigger cellular response to chemotherapy-induced DNA damage
Natalia F. Krynetskaia et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
High Mobility Group Box2 Promoter-controlled Suicide Gene Expression Enables Targeted Glioblastoma Treatment
Poonam Balani et al.
MOLECULAR THERAPY (2009)
MGMT METHYLATION IS A PROGNOSTIC BIOMARKER IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
E. R. Gerstner et al.
NEUROLOGY (2009)
Mechanism of DNA flexibility enhancement by HMGB proteins
Jingyun Zhang et al.
NUCLEIC ACIDS RESEARCH (2009)
Overexpression of high mobility group (HMG) B1 and B2 proteins directly correlates with the progression of squamous cell carcinoma in skin
Ashok Sharma et al.
CANCER INVESTIGATION (2008)
Correlation of O6-Methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity
Monika E. Hegi et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Increased expression of high mobility group box 1 (HMGB1) is associated with progression and poor prognosis in human nasopharyngeal carcinoma
D. Wu et al.
JOURNAL OF PATHOLOGY (2008)
Malignant gliomas in adults
Patrick Y. Wen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
HMGB1 as an autocrine stimulus in human T98G glioblastoma cells: role in cell growth and migration
Rosaria Bassi et al.
JOURNAL OF NEURO-ONCOLOGY (2008)
Essential roles of high-mobility group box 1 in the development of murine colitis and colitis-associated cancer
Shin Maeda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Masquerader: High mobility group box-1 and cancer
Jessica E. Ellerman et al.
CLINICAL CANCER RESEARCH (2007)
HMG chromosomal proteins in development and disease
Robert Hock et al.
TRENDS IN CELL BIOLOGY (2007)
SET complex in serous epithelial ovarian cancer
Veronique Ouellet et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
The characterization of the invasion phenotype of uveal melanoma tumour cells shows the presence of MUC18 and HMG-1 metastasis markers and leads to the identification of DJ-1 as a potential serum biomarker
Maria Pardo et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Altered expression and localization of creatine kinase B, heterogeneous nuclear ribonucleoprotein F, and high mobility group box 1 protein in the nuclear matrix associated with colon cancer
M Balasubramani et al.
CANCER RESEARCH (2006)
Cyclin E expression in breast cancer:: predicting germline BRCA1 mutations, prognosis and response to treatment
PO Chappuis et al.
ANNALS OF ONCOLOGY (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
HMGB1 and HMGB2 cell-specifically down-regulate the p53-and p73-dependent sequence-specific transactivation from the human Bax gene promoter
M Stros et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
HMG 1 and 2: architectural DNA-binding proteins
JO Thomas
BIOCHEMICAL SOCIETY TRANSACTIONS (2001)
Increased extracellular matrix remodeling is associated with tumor progression in human hepatocellular carcinomas
N Théret et al.
HEPATOLOGY (2001)
Membrane-type matrix metalloproteinases (MT-MMP)s: expression and function during glioma invasion
HL Fillmore et al.
JOURNAL OF NEURO-ONCOLOGY (2001)
Germline BRCA1/2 mutations and p27Kip1 protein levels independently predict outcome after breast cancer
PO Chappuis et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Steroid hormones induce HMG1 overexpression and sensitize breast cancer cells to cisplatin and carboplatin
Q He et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
